These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2489237)

  • 41. Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome.
    Maldonado R; Daugé V; Callebert J; Villette JM; Fournié-Zaluski MC; Feger J; Roques BP
    Eur J Pharmacol; 1989 Jun; 165(2-3):199-207. PubMed ID: 2776828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An in vitro study on the hippocampal electrophysiological properties of enkephalinase inhibitors in rats.
    Proietti ML; Sagratella S; Frank C; Trampus M; Scotti de Carolis A
    Pharmacol Biochem Behav; 1991 May; 39(1):119-21. PubMed ID: 1924493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
    Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W
    Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens.
    Blum K; Wallace JE; DeLallo L; Briggs AH
    Funct Neurol; 1986; 1(2):156-64. PubMed ID: 3301556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative.
    Waksman G; Bouboutou R; Chaillet P; Devin J; Coulaud A; Hamel E; Besselievre R; Costentin J; Fournie-Zaluski MC; Roques BP
    Neuropeptides; 1985 Feb; 5(4-6):529-32. PubMed ID: 3839056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan.
    Chipkin RE; Latranyi MZ; Iorio LC; Barnett A
    Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enkephalin dipeptidyl carboxypeptidase (enkephalinase) activity: selective radioassay, properties, and regional distribution in human brain.
    Llorens C; Malfroy B; Schwartz JC; Gacel G; Roques BP; Roy J; Morgat JL; Javoy-Agid F; Agid Y
    J Neurochem; 1982 Oct; 39(4):1081-9. PubMed ID: 6811698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1993 Sep; 242(2):145-50. PubMed ID: 8253111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2S,3R 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives, enkephalinase inhibitors, augment met5-enkephalin-induced antinociception.
    Matsuoka Y; Satoh S; Uruno T; Kubota K
    Jpn J Pharmacol; 1988 Mar; 46(3):205-10. PubMed ID: 3164081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin).
    Ukai M; Toyoshi T; Kameyama T
    Neuropharmacology; 1989 Oct; 28(10):1033-9. PubMed ID: 2554179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
    Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
    Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opiate-like peptides. Part VIII. Methylamides and dimethylamides of [D-Leu5]-enkephalin and [D-Ala2, D-Leu5]-enkephalin. Synthesis and analgesic activity.
    Rolka K; Kolasa K; Kleinrok Z; Kupryszewski G
    Pol J Pharmacol Pharm; 1986; 38(4):391-402. PubMed ID: 3534824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    Tseng LF; Cheng SS; Fujimoto JM
    J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorogenic substrates for the enkephalin-degrading neutral endopeptidase (Enkephalinase).
    Rush RS; Mitas M; Powers JC; Tanaka T; Hersh LB
    Arch Biochem Biophys; 1984 Jun; 231(2):390-9. PubMed ID: 6375573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.